Dermawerx Zmt Pak
NDC Package 69329-600-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Dermawerx Zmt Pak is tretinoin gel and cream are indicated for topical application in the treatment of acne vulgaris. Marketed by Patchwerx Labs, Inc., this product is identified by NDC 69329-600 and is authorized under FDA application ANDA075264.

Identification & Billing

NDC Package Code
69329-600-30
Package Description
1 KIT in 1 CARTON * 113 g in 1 TUBE (0799-0001-04) * 20 g in 1 TUBE
Product Code
69329-600
11-Digit Billing Format
69329060030
RxNorm Crosswalk
  • RxCUI: 106302 - tretinoin 0.025 % Topical Cream
  • RxCUI: 106302 - tretinoin 0.25 MG/ML Topical Cream
  • RxCUI: 1946476 - lanolin 15.7 % / menthol 0.44 % / petrolatum 24 % / zinc oxide 20.6 % Topical Ointment
  • RxCUI: 1946476 - lanolin 0.157 MG/MG / menthol 0.0044 MG/MG / petrolatum 0.24 MG/MG / zinc oxide 0.206 MG/MG Topical Ointment
  • RxCUI: 1946476 - Lanolin 0.157 MG/MG / Menthol 0.0044 MG/MG / Petrolatum 0.24 MG/MG / ZNO 0.206 MG/MG Topical Ointment

Clinical Specifications

Proprietary Name
Dermawerx Zmt Pak
Dosage Form
-
Usage Information
Tretinoin gel and cream are indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established.

Regulatory & Marketing

Labeler Name
Patchwerx Labs, Inc.
FDA Application #
ANDA075264
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-08-2015
Listing Expiration
12-31-2018
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69329-600-30 identifies a specific commercial package of 1 kit in 1 carton * 113 g in 1 tube (0799-0001-04) * 20 g in 1 tube of Dermawerx Zmt Pak, labeled by Patchwerx Labs, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Patchwerx Labs, Inc. on September 08, 2015. The current certification is valid through December 31, 2018.

How is this Patchwerx Labs, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69329060030. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69329-600-30
11-Digit CMS (5-4-2)
69329-0600-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.